Pfizerbiontech

Pfizer-BioNTech vaccine offers over 95 percent protection against COVID-19, says largest real-world study

The global use of the Pfizer/BioNTech vaccine is limited by supply issues, high costs, and ultra-cold chain storage requirements.

Pfizer/BioNTech seeks EU's approval to vaccinate children between ages 12-15 years

BioNTech CEO Ugur Sahin said ongoing trials are "very encouraging" and that "children are very well protected by the vaccine".

Johnson & Johnson's upcoming COVID-19 vaccine trials to include infants

Pfizer-BioNTech and Moderna plan to gradually test their vaccines in younger and younger age groups.

Coronavirus mutant variant: What is the spike protein and why is it so important?

The new variant carries several peculiar changes to the spike protein when compared to other closely related variants.

Mike Pence receives Pfizer shot on camera as US govt ups efforts to build confidence on vaccine efficacy

Describing it as the beginning of the end of the coronavirus pandemic, Pence noted that there is a long way to go given that there has been an increase in cases rising across the country, including in hospitalisations